Cytiva

Cytiva

@Cytiva

Followers15.3K
Following1.4K

At Cytiva, our vision is a world in which access to life-changing therapies transforms human health.

Global
Joined on August 16, 2011
Statistics

We looked inside some of the tweets by @Cytiva and here's what we found interesting.

Inside 100 Tweets

Time between tweets:
4 hours
Average replies
0
Average retweets
1
Average likes
2
Tweets with photos
15 / 100
Tweets with videos
5 / 100
Tweets with links
0 / 100

Rankings (sorted by number of followers)

33. globally and in category HealthCare

159. in category HealthCare

Cytiva
14 hours ago

“Resistance to the gold-standard malaria treatment, the drug artemisinin, has been rising in southeast Asia for a decade — and there is evidence that artemisinin-based therapies might start to fail in Rwanda, too.” — via @nresearchnews #malaria #resistance https://t.co/lGxxZrRwAG

Cytiva
16 hours ago
Like chromotography, the Scandinavians also discovered the popular protein A. But what makes it so special? What about protein G or L? Surely protein A is not the most popular because of alphabetical order? #DiscoveryMatters

Find out more: https://t.co/dVcUoDVR7P https://t.co/j25AzIVLle

Like chromotography, the Scandinavians also discovered the popular protein A. But what makes it so special? What about protein G or L? Surely protein A is not the most popular because of alphabetical order? #DiscoveryMatters Find out more: https://t.co/dVcUoDVR7P https://t.co/j25AzIVLle

Cytiva
17 hours ago

Does you high-performance liquid chromatography (HPLC) system need attention? Discover how you can recognize visible signs of in-system issues, identify potential problems and determine solutions that extend the usable lifetime of a column. https://t.co/ArfG4b9EW8

Cytiva
19 hours ago

“Researchers have now identified a protein called histone deacetylase 3 (HDAC3) as the orchestrator of the immune system's inflammation response to infection.” — via @ScienceDaily https://t.co/hrtqw40lUg

Cytiva
a day ago

“GW Cancer Center researchers demonstrate for the first time that HDAC6 inhibitors drugs can both improve response to immunotherapy and diminish the invasiveness of breast cancer.” — via @EurekAlert #breastcancer #immunotherapy https://t.co/712fm4mlms

Cytiva
2 days ago

“Eosinophils residing in the airways of mice respond to influenza A virus (IAV) infection through alterations in surface expression of various markers necessary for migration and cellular immunity responses...” — via @EurekAlert #influenza #virus https://t.co/fWOClPMx1T

Cytiva
2 days ago

Managing host cell protein (HCP) is critical to quality control in #biologics. Join us Sept. 9 to learn how to design an HCP control strategy that builds confidence and ensures accuracy. #hcp #hcpanalysis Register via: https://t.co/xTEPgITEDZ

Cytiva
2 days ago

Register for our free webinar with Steve Lamonica to learn proper cleaning protocols, best practices from our field service engineers and technical leaders for your BioProcess system. Learn more! https://t.co/wCYIsgFobR

Cytiva
2 days ago

“Researchers have now shown how gut microbes reprogram the repertoire of white blood B cells that produce antibodies and how this helps counter infections.” — via @ScienceDaily #microbiota #gutmicrobes https://t.co/gvwfbQ3zRz

Don't miss @Cytiva president and CEO himself, Emmanuel Ligner, share his valuable insight into the future of #tech and Life Science. 💊🧪 at @UPPSTART. FREE tickets to this virtual keynote here: https://t.co/ijmCefpNnJ

Cytiva
2 days ago

“Sars-CoV-2 infects a person by first binding its spike protein to the ACE2 receptor on the surface of human cells. Blocking this process could theoretically inhibit infections when tissues are exposed to the virus.” — via @FierceBiotech https://t.co/BBwKIQTXML

Cytiva
3 days ago

“An experimental vaccine against SARS-CoV-2 has been shown to elicit neutralizing antibodies and a helpful T-cell response with the aid of a carefully engineered spike protein that mimics the infection-spreading part of the virus.” — via @EurekAlert #COVID https://t.co/B5gkP2gqER

Cytiva
3 days ago

Meet a member of our diagnostics team: Dominik de Cassan. Senior specialist R&D. He talks about what motivates him every day dealing with real problems and real products. With the goal of helping customers overcome their problems. #Diagnostics https://t.co/FsjhZW9fWu

Cytiva
3 days ago

Do you think of the DNA double helix as a minuscule mechanical spring? 🧬 In previous experiments DNA molecules have shown strange mechanical properties. Scientists can now explain these properties, providing great insights for medicine and biology. #DNA https://t.co/woCNhDqrTH

Cytiva
3 days ago
Like chromotography, the Scandinavians also discovered the popular protein A. But what makes it so special? What about protein G or L? Surely protein A is not the most popular because of alphabetical order? #DiscoveryMatters

Find out more: https://t.co/dVcUoDVR7P https://t.co/0jOqsTTobR

Like chromotography, the Scandinavians also discovered the popular protein A. But what makes it so special? What about protein G or L? Surely protein A is not the most popular because of alphabetical order? #DiscoveryMatters Find out more: https://t.co/dVcUoDVR7P https://t.co/0jOqsTTobR

Cytiva
3 days ago

Chimeric antigen receptor (CAR) T cells show promise as cancer therapeutics but what challenges must be resolved before they become clinically useful? #cancer #therapeutics https://t.co/NyHGnNyPbE

Cytiva
3 days ago

Business of Biotech features @ArrowheadPharma CEO Dr. Christopher Anzalone discussing the indications his company is targeting beyond liver disease. $ARWR #businessofbiotech #biopharma #podcast #RNAi https://t.co/qLEmf88H9p

Cytiva
3 days ago

Join Robyn | She will talk about the characterization of lead candidates via epitope binning studies. #Biacore https://t.co/rH4xIcNcEx

Cytiva
4 days ago

“Scientists at EPFL's Brain Mind Institute have identified an enzyme that can play a central role in developing a new route of treatment for Huntington's Disease.” — via @EurekAlert #discovery https://t.co/ikCjjGmrIq

Cytiva
4 days ago
Want to optimize your HCP ELISAs? Understanding your options can help. Download our visual guide for a clear summary of the steps, strengths, and weaknesses of differential gel approaches – and make an informed decision that enhances your processes.

https://t.co/3n8Nk45yFr https://t.co/tYiwCIkLFq

Want to optimize your HCP ELISAs? Understanding your options can help. Download our visual guide for a clear summary of the steps, strengths, and weaknesses of differential gel approaches – and make an informed decision that enhances your processes. https://t.co/3n8Nk45yFr https://t.co/tYiwCIkLFq

Next Page